Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

Peptide Database

265 therapeutic peptides with research summaries, clinical findings, and regulatory status.

Showing 1–7 of 7 in PerformanceClear filters
PerformanceResearch Phase

Melanotan II

A synthetic cyclic analog of alpha-melanocyte stimulating hormone (alpha-MSH) that non-selectively activates melanocortin receptors MC1R through…

Subcutaneous injection
PerformanceResearch Phase

IGF-1 LR3 (Long-Arg3)

IGF-1 LR3 is a synthetic analogue of insulin-like growth factor 1 with an N-terminal extension of 13 amino acids and a substitution of arginine for…

Subcutaneous injection
PerformanceResearch Phase

IGF-1 DES (1-3)

IGF-1 DES (1-3) is a truncated analogue of insulin-like growth factor 1 lacking the first three N-terminal amino acids (glycine-proline-glutamate).…

Subcutaneous injection
PerformanceResearch Phase

MGF (Mechano Growth Factor)

Mechano Growth Factor is a splice variant of the IGF-1 gene expressed in response to mechanical stress on muscle tissue. The peptide contains a…

Intramuscular injection
PerformanceResearch Phase

PEG-MGF

PEG-MGF is a pegylated derivative of Mechano Growth Factor designed to extend systemic half-life through the addition of polyethylene glycol…

Subcutaneous injection
PerformanceResearch Phase

Follistatin-344

Follistatin-344 is a 344-amino acid glycoprotein that functions as a binding protein and endogenous antagonist of myostatin and other members of the…

Intramuscular injection, Gene delivery
PerformanceInvestigational

ACE-031 (Ramatercept)

ACE-031 is a recombinant fusion protein combining the extracellular domain of the activin receptor type IIB with a human IgG1 Fc domain. This soluble…

Subcutaneous injection

All 265 peptides

Complete index, every profile, one click away.

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association reviews licensure but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. HIPAA-compliant infrastructure. The Peptide Association is not a medical practice.